The 20 Best Metastatic Insulinoma Doctors Near Me in Houston, TX
Find the Top Metastatic Insulinoma Experts and Specialists
The 20 Best Metastatic Insulinoma Doctors near Houston, TX
MediFind found 21 doctor with experience in Metastatic Insulinoma near Houston, TX. Of these, 15 are Experienced, 5 are Advanced and 1 are Distinguished.
MD Anderson
Ching-wei Tzeng is a Surgical Oncologist in Houston, Texas. Dr. Tzeng is rated as an Advanced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Hepatectomy, and Pancreatectomy.
Dr. Tannaz Armaghany is Assistant Professor of Medicine-Hematology and Oncology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.Dr. Armaghany’s professional interests include: gastrointestinal medical oncology, neuroendocrine tumors, hepatocellular carcinoma, and hepatobiliary cancers.Dr. Armaghany received her medical degree from Tabriz University in Tabriz, Iran and completed her residency at Cook County Hospital in Chicago, Ill. She also completed fellowships in hematology and medical oncology at Louisiana State University Health in Shreveport, La. and integrative medicine at Arizona State University in Tucson, Ariz.Dr. Armaghany is board-certified in Medical Oncology, Hematology, and Internal Medicine from the American Board of Internal Medicine.Dr. Armaghany serves as President of the Texas branch of the Iranian American Medical Association. She is also a member of American College of Clinical Oncology, American Society of Hematology, North American Neuroendocrine Tumor Society, SWOG Cancer Research Network, Harris County Medical Society, International Society of Liver Cancer, and the Texas Medical Association. Dr. Armaghany is rated as an Advanced provider by MediFind in the treatment of Metastatic Insulinoma. Her top areas of expertise are Neuroendocrine Tumor, Fibrolamellar Carcinoma, Gallbladder Adenocarcinoma, and Gallbladder Cancer.
UT MD Anderson Cancer Center
Nageshwara Dasari is an Oncologist in Houston, Texas. Dr. Dasari is rated as an Advanced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Neuroendocrine Tumor, Colorectal Cancer, Familial Colorectal Cancer, and Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).
UT MD Anderson Cancer Center
Michael Kim is a Surgical Oncologist in Houston, Texas. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Splenectomy.
Office
David Fogelman is an Oncologist in Houston, Texas. Dr. Fogelman is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Pancreatic Ductal Adenocarcinoma, Pancreatoblastoma, Ampullary Cancer, Pancreaticoduodenectomy, and Pancreatectomy.
MD Anderson
Matthew Katz is a Surgical Oncologist and a General Surgeon in Houston, Texas. Dr. Katz is rated as an Advanced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.
MD Anderson
Jeffrey Lee is a Surgical Oncologist and a General Surgeon in Houston, Texas. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia, Familial Pancreatic Cancer, Small Bowel Resection, and Pancreatectomy.
Dr. William E. Fisher is Professor and Vice-Chair for Clinical Affairs, Department of Surgery and the George L. Jordan, M.D. Chair in General Surgery at Baylor College of Medicine. Dr. Fisher also serves as Director of the Elkins Pancreas Center at BCM; and is Vice President, Medical Staff and Chief of the Surgery Service Line at Baylor St. Luke’s Medical Center.An internationally-known leader in pancreatic surgery, Dr. Fisher has focused entirely on surgery for pancreatic tumors and cysts in his practice for over 20 years and has extensive experience in advanced, minimally-invasive robotic pancreas surgery.Dr. Fisher’s professional interests include: pancreaticoduodenectomy (Whipple procedure); minimally invasive/laparoscopic/robotic pancreatic surgery; pancreas cancer; distal and central pancreatectomy; pancreas resection; surgical oncology; common bile duct resection; Puestow procedure; Frey procedure; and laparoscopic pancreatectomy.Dr. Fisher has served as PI of two NIH-funded multicenter randomized clinical trials that generated practice-changing impact on the use of drains during pancreatectomy, and the subsequent development of a multicenter pancreatic-surgery-outcomes consortium. His basic science lab has studied the influence of gastrointestinal hormones on pancreatic cancer growth, the relationship between diabetes and pancreatic cancer, and genomic analysis of pancreatic cancer, resulting in over 160 peer-reviewed publications.Having served as principal investigator on more than 15 clinical trials for patients with pancreatic cancer, Dr. Fisher is currently PI at BCM for the NIH Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer.Dr. Fisher received a B.A. from Wittenberg University and earned his medical degree from the University of Cincinnati College of Medicine. He held a research fellowship and completed his residency at The Ohio State University.Among his numerous honors and awards, Dr. Fisher has been recognized as one of America’s Top Doctors for Cancer (Castle Connolly Medical Ltd.), Top 1% of Doctors in the U.S. (U.S. News and World Report), and “Texas Super Doctor” (Texas Monthly). He is also the recipient of the Master Clinician Award for Excellence in Patient Care from BCM and has twice received the DeBakey Distinguished Service Award from the Michael E. DeBakey Department of Surgery at BCM. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Chronic Pancreatitis, Pancreatic Cancer, Hereditary Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy.
Kelsey Seybold Clinic
Sunil Patel is an Oncologist in Houston, Texas. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Metastatic Insulinoma, Pancreatic Islet Cell Tumor, Colorectal Cancer, and Glucagonoma.
UT MD Anderson Cancer Center
Naruhiko Ikoma is a Surgical Oncologist in Houston, Texas. Dr. Ikoma is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Stomach Cancer, Pancreatic Cancer, Gastrointestinal Fistula, Gastrectomy, and Pancreaticoduodenectomy.
UT MD Anderson Cancer Center
Jordi Ahnert is an Oncologist in Houston, Texas. Dr. Ahnert is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Synovial Sarcoma, Pancreatic Cancer, and Metastatic Pleural Tumor.
UT MD Anderson Cancer Center
Shubham Pant is an Oncologist in Houston, Texas. Dr. Pant is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Hepato-Pancreato-Biliary Surgery, and Pancreatectomy.
MD Anderson
Jenny Li is an Oncologist and a Hematologist Oncology provider in Houston, Texas. Dr. Li is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. Her top areas of expertise are Stomach Cancer, Gastroesophageal Junction Cancer, Esophageal Cancer, and Chronic Myelogenous Leukemia (CML).
UT MD Anderson Cancer Center
Alisha Bent is a primary care provider, practicing in Oncologist in Houston, Texas. Dr. Bent has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, and Stomach Cancer.
UT MD Anderson Cancer Center
Phat Le is a Hematologist and an Oncologist in Houston, Texas. Dr. Le has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Colorectal Cancer, Gallbladder Cancer, Gallbladder Adenocarcinoma, and Ampullary Cancer.
Office
Putao Cen is an Oncologist in Houston, Texas. Dr. Cen is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. Her top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Clear Cell Sarcoma, Chromophobe Renal Cell Carcinoma, and Pancreaticoduodenectomy.
OC Pharmacy II
William Velasquez is a Hematologist in Houston, Texas. Dr. Velasquez is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Childhood Iron Deficiency Anemia, Thrombocytopenia, Iron Deficiency Anemia, and Anemia.
OC Pharmacy II
Kathy Sam is an Oncologist in Houston, Texas. Dr. Sam is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. Her top areas of expertise are Drug-Induced Thrombocytopenia, Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, and Paget Disease of the Breast.
MD Anderson
Jean Vauthey is a Surgical Oncologist in Houston, Texas. Dr. Vauthey is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Liver Cancer, Hepatectomy, and Hepato-Pancreato-Biliary Surgery.
Oncology Consultants P. A.
Julio Peguero is an Oncologist in Houston, Texas. Dr. Peguero is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, and Tissue Biopsy.
Last Updated: 02/22/2026




